Title: Founding Director of the Division of Radiation Health
Company: University of Arkansas for Medical Sciences
Location: Little Rock, Arkansas, United States
Martin Hauer-Jensen, founding director of the division of radiation health at University of Arkansas for Medical Sciences, has been recognized by Marquis Who’s Who Top Doctors for dedication, achievements, and leadership in health care.
Dr. Hauer-Jensen’s professional journey began at The Norwegian Radium Hospital in 1989 as a staff surgeon and clinical trials office director. He furthered his career at the University of Arkansas for Medical Sciences (UAMS) as chief resident of surgery from 1990 to 1991. Transitioning roles at UAMS, he evolved from an instructor to an assistant professor of surgery and pathology, ultimately attaining the esteemed position of professor. His dedication to medical education and research culminated in his role as a professor of surgery and pathology at UAMS since 1999. Simultaneously, from 2008 to 2023, he significantly contributed as the director of the division of radiation health, associate dean for research at the College of Pharmacy, and professor of pharmaceutical sciences at UAMS.
Dr. Hauer-Jensen’s academic journey commenced with a Doctor of Medicine from the University of Oslo (UiO) in 1977. He subsequently earned a PhD in radiation biology from the same institution in 1988. Demonstrating his academic prowess and expertise in radiation biology and its profound impact on the gastrointestinal tract, he has authored over 300 scientific articles and book chapters.
As a dedicated surgeon and researcher, Dr. Hauer-Jensen’s pivotal focus on radiation research within normal tissues, particularly the gastrointestinal tract, marks the zenith of his career. His pioneering investigations, generously funded by esteemed institutions like the National Cancer Institute (NCI), epitomize his commitment to advancing medical knowledge in radiation biology. His vision for the future involves fostering growth and success within the division he founded at UAMS 15 years ago, nurturing innovative initiatives for the betterment of radiation biology.
Dr. Hauer-Jensen attributes his success to fortuitous timing and aligning opportunities with his expertise. His groundbreaking work in radiation enteropathy and intestinal radiation injury, initiated in Norway and refined during his tenure in Iowa City, is a testament to this. His ongoing work on Gamma Tocotrienol, a potential radioprotector close to FDA approval, underscores his enduring commitment to advancing medical solutions in radiation biology.
For more information, please visit:
LinkedIn
Press Release
Contact Dr. Hauer-Jensen:
